Company Filing History:
Years Active: 1993-1996
Title: Innovations of Yoshimori Sakuma
Introduction
Yoshimori Sakuma is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the pharmaceutical field, particularly through his innovative work on 1,4-diazepine derivatives. With a total of seven patents to his name, Sakuma's inventions are aimed at addressing various medical challenges, especially allergic diseases.
Latest Patents
Sakuma's latest patents include a triazolo-1,4-diazepine compound that is useful in treating allergic diseases. The compound is described by a specific formula where R¹ and R² can be hydrogen or an alkyl, R³ is hydrogen or a halogen, R⁴ is hydrogen or an alkyl, X can be --OCO--, and Y can be a cycloalkyl, a cycloalkylalkyl, an alkynyl, or others. Another patent focuses on a similar triazolo-1,4-diazepine compound, which also serves a pharmacological purpose in treating allergic conditions.
Career Highlights
Sakuma is currently employed at Eisai Company, Limited, where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of allergic diseases through his patented compounds.
Collaborations
Sakuma has collaborated with notable colleagues such as Kazuo Okano and Shuhei Miyazawa, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yoshimori Sakuma's contributions to the field of pharmaceuticals through his patents on 1,4-diazepine derivatives highlight his role as a significant inventor. His work not only showcases his innovative spirit but also aims to improve the quality of life for those suffering from allergic diseases.